Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

NCT03592121 is registered in ClinicalTrials.gov with Applied Biology, Inc. as lead sponsor.

NCT NCT03592121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03592121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Investigate the Effect of AB-101 in Breast Cancer Survivors
Lead sponsor
Applied Biology, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 9, 2018
Completion date
October 12, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer of breast, neuropathy, nipple disorder, sexual arousal disorder, sexual dysfunction, sexual dysfunction, physiological